Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 431-060-1 | CAS number: 153719-38-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February - April 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study; documentation sufficient for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5375 (In Vitro Mammalian Chromosome Aberration)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- This study was performed in compliance with Good Laboratory Practice (GLP) in Switzerland, Procedures and Principles, March 1986, issued by the Federal Department of the Interior and the Intercantonal Office for the Control of Medicaments, Switzerland.
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- -
- EC Number:
- 431-060-1
- EC Name:
- -
- Cas Number:
- 153719-38-1
- Molecular formula:
- C4H8N4O3
- IUPAC Name:
- 3-methyl-N-nitro-3,6-dihydro-2H-1,3,5-oxadiazin-4-amine
- Details on test material:
- - Name of test material (as cited in study report): CA 2343 A (Intermediate of CGA 293343)
- Physical state: fine, white powder
- Analytical purity: 96.7 %
- Batch No.: P.503005
- Stability under test conditions: stable
- Storage condition of test material: room temperature
- Reanalysis date: December 31, 1996
Constituent 1
Method
- Target gene:
- ATCC (American Type Culture Collection) CCL 61 (ovary, Chiense hamster, CHO K1)
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - Test organism: ATCC (American Type Culture Collection) CCL 61 (ovary, Chiense hamster, CHO K1)
- Type and identity of media: culture medium consisting of Nutrient Mixture F-12 supplemented with 10 % fetal calf serum + Penicillin/Streptomycin 100 units/ml/ 100 µg/ml (Gibco AG, Basle, Switzerland) in 75 cm² tissue-culture (plastic) flasks; the cultures were incubated at 37 °C in a humidified atmosphere containing 5 % CO2; the cells were passaged twice weekly
- duration of normal cell cycle: 12 - 13 hours
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- post mitochondrial supernatant (S9 fraction) from Aroclor 1254 induced rat liver
- Test concentrations with justification for top dose:
- Experiment without metabolic activation:
21 hours treatment time:
original experiment: 312.5, 625, and 1250.0 µg/ml
confirmatory experiment: 625, 937.5, and 1250.0 µg/ml
Experiment with metabolic activation:
3 hours treatment followed by 18 hours recovery period:
original experiment: 1250.0, 2500.0 and 5000 µg/ml
confirmatory experiment: 2500.0, 3750.0 and 5000 µg/ml - Vehicle / solvent:
- Solvent used:
- culture medium without activation
- nutrient mixture F-12 (HAM) with activation
Controlsopen allclose all
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation
Migrated to IUCLID6: (KYOWA KAKKO KOGYO CO. Ltd., Japan), 0.2 µg/ml
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
Migrated to IUCLID6: (ASTA-Werke, Germany), 20.0 µg/ml
- Untreated negative controls:
- yes
- Remarks:
- vehicle
- Remarks:
- set in each experiment
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 24 hours
- Exposure duration: Experiment without metabolic activation: 21 hours treatment time; Experiment with metabolic activation: 3 hours treatment followed by 18 hours recovery period
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays): orcein
NUMBER OF INDEPENDENT EXPERIMENTS:
- three experiments without metabolic activation (twice 21 hours and once 45 hours)
- three trials with metabolic activationm (twice 21 hours and once 45 hours)
NUMBER OF REPLICATES:
- 2 cultures evaluated per concentration
NUMBER OF CELLS EVALUATED (per concentration):
- 200 (whenever possible; except positive controls)
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes;
- Determination of endoreplication: yes;
RAT-LIVER POST MITOCHONDRIAL SUPERNATANT:
- male RAI rats (Tif: RaIf[SPF]) treated with Aroclor 1254 5 days prior to sacrifice
- livers were homogenized with 3 volumes of 150 ml KCl
- homogenate was centrifuged at 9000x g for 15 min
- S9 protein content: 36.80 mg/ml
- concentrations in S9 mixture used: rat liver S9 fraction 150 µl/ml, NADP 31.4 µmol/ml, Isocitric acid (trisodium salt) 153 µmol/ml
- sterilasation: filtration through a 0.22 µm filter
- final S9 concentration during treatment: 1.5 % - Evaluation criteria:
- Criteria for positive reponse:
- the percentage of metaphases containing specific aberrations in a treatment group is higher than 6.0 (based on historical negative control range) and differs statistically significant from the respective value of the negative control
- a concentration-related response should be demonstrable
Criteria for negative response:
- the percentage of metaphases containing specific aberrations in a treatment group is less than or equal 6.0 (based on historical negative control range) and does not differ statistically significant from the respective value of the negative control
Exceptions:
At the limits of the criteria for a positive or for a negative response or if the criteria for a positive response are only partially fulfilled or if effects are obtained at extremely high concentrations or in the toxic range of the test substance only, the Study Director will decide by experience about the interpretation of the results.
Assay acceptance criteria:
- The results of the experiments should not be influenced by a technical error, contamination or a recognized artefact
- The quality of the slide should allow, at least to a large extent, the chromosomes to be easily identifiable
- In the negative controls the percentage of metaphases showing specific chromosomal aberrations should be less than 6.0 (based on historical negative control range).
- The results of the positive control experiments should meet the criteria for a positive response.
- The highest concentration to which cells were exposed in the mutagenicity test should exert sufficient toxicity (suppression of miotic activity by 50 % or more), represent the limit of solubility of the test material, or be at least 5 mg/ml (or 10 mMol/l). - Statistics:
- The evaluated numbers of specific aberrations were subjected to statistical analysis. In the preliminary tests the data were assessed for flask effects (dependence of cells within each culture) using chi-squared test. The nonsignificant result of this test means there is no substantial evidence to conclude a flask effect (although a flask effect still might exist). Accordingly, a chi-squared test for trend was performed modelling all cells in a given experiment as independent. That is, the individual cell is taken as the experimental unit. Consequently the power of the test is substantially increased, resulting in a rather safe judgement of the observed effects.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Remarks:
- no statistically significant increase in the number of metaphases containing specific chromosomal aberrations was observed; the incidence of aberrant cells was within the historical control range at all doses assessed
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The highest conc. of 1250.0 µg/ml selected for chromosome analysis in the first experiment caused 21.9% suppression of mitotic activity. The next highest conc. of 2500.0 µg/ml could not be scored due to toxicity.
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- a statistically significant and concentration-dependant increase in the numbers of metaphases containing specific chromosomal aberrations was observed
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The highest concentration of 5000.0 µg/ml selected for chromosome analysis in the second experiment caused 38.62 % suppression of mitotic activity.
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Remarks:
- no statistically significant increase in the number of metaphases containing specific chromosomal aberrations was observed; the incidence of aberrant cells was within the historical control range at all doses assessed
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The highest conc. of 1250.0 µg/ml selected for chromosome analysis in the first experiment (confirmatory exp.) caused 2.68% suppression of mitotic activity. The next highest conc. of 1875.0 µg/ml could not be scor
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- a statistically significant and concentration-dependant increase in the numbers of metaphases containing specific chromosomal aberrations was observed
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The highest conc. of 1250.0 µg/ml selected for chromosome analysis in the second experiment (confirmatory experiment) caused 60.61 % suppression of mitotic activity.
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No chromosome aberrations were scored in the experiments of the confirmatory studies due to the clear clastogenic eff. observed in the experiments with metab. activ. using the short treatment time (3hrs/15 hrs recovery).
- Cytotoxicity / choice of top concentrations:
- other: clear clastogenic effects => no slides were selected for scoring
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- ANALYTICAL RESULTS:
- concentration values found: 108.6 % and 105.6%
- the test substance is sufficiently stable in the vehicle
POSITIVE CONTROLS:
- the treatment of the cultures with mitomycin-C, 0.2 µg/ml and cyclophosphamide, 20.0 µg/ml, respectively, was followed by a high incidence of specific chromosomal aberrations in the experiments of the original study (60.0% and 64.0%) and in the experiments of the confirmatory study (64.0% and 68.0%)
COMPARISON WITH HISTORICAL CONTROL DATA: yes
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'. Remarks: 21 hours treatment (original study)
Any other information on results incl. tables
Original mutagenicity study:
- 21 hours treatment, without metabolic activation: 2.5 % metaphases with specific chromosomal aberrations were detected in the negative control; at the concentrations of 312.5 , 625.0 and 1250.0 µg/ml 3.5%, 0.5% and 3.0 % of cells with specific chromosomal aberrations were found
- 3 hours treatment / 18 hours recovery, with metabolic activation: 2.0 % metaphases with specific chromosomal aberrations were detected in the negative control; at the concentrations of 1250.0, 2500.0 and 5000.0 µg/ml 3.5%, 8.5% and 44 % of cells with specific chromosomal aberrations were found
Confirmatory mutagenicity study:
- 21 hours treatment, without metabolic activation: 1.5 % metaphases with specific chromosomal aberrations were detected in the negative control; at the concentrations of 625.0, 937.5 and 1250.0 µg/ml 2.5%, 0.5% and 1.5 % of cells with specific chromosomal aberrations were found
- 3 hours treatment / 18 hours recovery, with metabolic activation: 2.5 % metaphases with specific chromosomal aberrations were detected in the negative control; at the concentrations of 2500.0, 3750.0 and 5000.0 µg/ml 7.5%, 18.5% and 66 % of cells with specific chromosomal aberrations were found
In the original experiment with metabolic activation the numbers of cells containing specific chromosomal aberrations obtained at the concentrations of 2500.0 and 5000.0 µg/ml showed a statistically significant and concentration-dependent increase. In the confirmatory experiment with metabolic activation, a similar effect was registered at the concentrations of 2500, 3750 and 5000 µg/ml. In both experiments performed with metabolic activation, also increased frequencies of endoreduplications and polyploidy metaphases were observed at subtoxic concentrations.
Unspecific chromosomal aberrations in the form of chromatid gaps found in all experiments were within the frequency generally observed.
Applicant's summary and conclusion
- Conclusions:
- It is concluded that under the given experimental conditions evidence of clastogenic effects was obtained in Chinese hamster ovary cells in vitro treated with CA 2343 A (Intermediate of CGA293343) in the presence and absence of metabolic activation. No effect occurred in the absence of metabolic activation.
- Executive summary:
CA 2343 A (Intermediate of CGA 293343), identified as a fine white powder, 96.7 % purity, batch no. P.503005, was investigated for clastogenic (chromosome-damaging) effects on Chinese Hamster ovary cells in vitro with and without metabolic activation (S9). The compound was dissolved in culture medium and tested at each of the following conditions:
Experiment without metabolic activation:
21 hours treatment time:
original experiment: 312.5, 625, and 1250.0 µg/ml
confirmatory experiment: 625, 937.5, and 1250.0 µg/ml
Final concentrations higher than 1250 µg/ml of culture medium could not be scored due to cytotoxicity. Mitomycin C (0.2 µg/ml) was used as a positive control in the 21 hours experiments.
Experiment with metabolic activation:
3 hours treatment followed by 18 hours recovery period:
original experiment: 1250.0, 2500.0 and 5000 µg/ml
confirmatory experiment: 2500.0, 3750.0 and 5000 µg/ml
Slight cytotoxicity was observed at the concentration of 5000 µg/ml. Cyclophosphamide (20.0 µg/ml) was used as a positive control in the 3 hours experiments.
In the two experiments performed without metabolic activation no statistically significant increase in the number of metaphases containing specific chromosomal aberrations was observed. The incidence of aberrant cells was within the historical control range at all doses assessed.
In the two experiments performed with metabolic activation a statistically significant and concentration-dependant increase in the numbers of metaphases containing specific chromosomal aberrations was observed.
No chromosome aberrations were scored in the experiments of the confirmatory studies (without and with metabolic activation, 45 hours treatment and 3 hours treatment/ 42 hours recovery) due to the clear clastogenic effects observed in the experiments with metabolic activation using the short treatment time (3 hours / 15 hours recovery).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)